Actively Recruiting
Effect of Misoprostol Given Before Elective Caesarean Section on Reducing Newborn Respiratory Problems in Pregnant Women Under 38 Weeks
Led by Kafrelsheikh University · Updated on 2025-05-13
160
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the use of Misoprostol before elective cesarean sections in pregnant women under 38 weeks of gestation to see if it can reduce the risk of breathing problems in newborns. This study focuses on preventing neonatal respiratory distress, which is common in babies delivered by cesarean section and can lead to complications like respiratory distress syndrome and the need for intensive care. Misoprostol is a medication that has a uterotonic effect and may help improve lung function in newborns. Participants will be randomly assigned to one of two groups one receiving 100 micrograms of Misoprostol one hour before their scheduled cesarean section, and the other receiving no treatment before surgery. The study evaluates the effect of this treatment on newborn respiratory health, particularly in babies born before 38 weeks gestation. Misoprostol is given orally and is known for being inexpensive, easy to store, and having few side effects. Throughout the study, researchers will monitor newborns for signs of respiratory distress shortly after birth, focusing on breathing rates in the first five minutes post-delivery. Women will be assessed before surgery to confirm eligibility, including verifying pregnancy age and health status. The main outcome measured is the incidence of transient tachypnea, a rapid breathing condition in newborns. The study will continue until August 2025 and includes safety monitoring and data collection related to newborn respiratory outcomes.
CONDITIONS
Brief Title
Misoprostol Before Caesarean Section
Research Team
M
Merna Ashraf Ahmed farid, M.B.B.C.H
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here